ES2137185T3 - Composicion y metodo para el tratamiento de desordenes de la despigmentacion. - Google Patents

Composicion y metodo para el tratamiento de desordenes de la despigmentacion.

Info

Publication number
ES2137185T3
ES2137185T3 ES92910389T ES92910389T ES2137185T3 ES 2137185 T3 ES2137185 T3 ES 2137185T3 ES 92910389 T ES92910389 T ES 92910389T ES 92910389 T ES92910389 T ES 92910389T ES 2137185 T3 ES2137185 T3 ES 2137185T3
Authority
ES
Spain
Prior art keywords
treatment
pct
date nov
disorders
pseudocatalases
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92910389T
Other languages
English (en)
Inventor
John Martin Wood
Karin Uta Schallreuter
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Stiefel Research Australia Pty Ltd
Stiefel Laboratories Inc
Original Assignee
Stiefel Research Australia Pty Ltd
Stiefel Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Stiefel Research Australia Pty Ltd, Stiefel Laboratories Inc filed Critical Stiefel Research Australia Pty Ltd
Application granted granted Critical
Publication of ES2137185T3 publication Critical patent/ES2137185T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/26—Iron; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/32—Manganese; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/34—Copper; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Mobile Radio Communication Systems (AREA)
  • Transceivers (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

EL VITIGILO Y OTROS TRASTORNOS DE DEPIGMENTACION POSITIVA DE TIROSINASA SON TRATADOS POR APLICACION TOPICA DE UN SEUDOCATALASA Y UNA SUBSIGUIENTE EXPOSICION A UNA DOSIS DE ERITEMA SUBMINIMA DE LUZ UVB. TRAS UNA SESION DE TRATAMIENTO, LA PIGMENTACION DE LAS AREAS AFECTADAS PUEDE MANTERNERSE POR TRATAMIENTO CON SUDOCATALASA SIN TRATAMIENTO DE LUZ UVB. LAS SEUDOCATALASAS PREFERIDAS SON COMPLEJOS DE COORDINACION DE METAL DE TRANSICION, ESPECIALMENTE BICARBONATO (I() DE MANGANESO.
ES92910389T 1991-05-15 1992-05-15 Composicion y metodo para el tratamiento de desordenes de la despigmentacion. Expired - Lifetime ES2137185T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB919110652A GB9110652D0 (en) 1991-05-15 1991-05-15 Composition and method of treating depigmentation disorders

Publications (1)

Publication Number Publication Date
ES2137185T3 true ES2137185T3 (es) 1999-12-16

Family

ID=10695131

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92910389T Expired - Lifetime ES2137185T3 (es) 1991-05-15 1992-05-15 Composicion y metodo para el tratamiento de desordenes de la despigmentacion.

Country Status (20)

Country Link
US (1) US5433942A (es)
EP (1) EP0584171B1 (es)
JP (1) JPH06510275A (es)
KR (1) KR100190978B1 (es)
AT (1) ATE183097T1 (es)
AU (1) AU649543B2 (es)
CA (1) CA2102514A1 (es)
DE (1) DE69229780T2 (es)
ES (1) ES2137185T3 (es)
GB (1) GB9110652D0 (es)
GR (1) GR3031483T3 (es)
IE (1) IE69854B1 (es)
IL (1) IL101871A (es)
MY (1) MY108848A (es)
NZ (1) NZ242748A (es)
PH (1) PH30792A (es)
SG (1) SG45381A1 (es)
TW (1) TW201695B (es)
WO (1) WO1992020354A1 (es)
ZA (1) ZA923561B (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0799018A4 (en) * 1994-12-21 2000-03-29 Cosmederm Technologies FORMULATIONS AND METHODS FOR REDUCING SKIN IRRITATION
US7404967B2 (en) 1994-12-21 2008-07-29 Cosmederm, Inc. Topical product formulations containing strontium for reducing skin irritation
US6139850A (en) * 1994-12-21 2000-10-31 Cosmederm Technologies Formulations and methods for reducing skin irritation
US6455076B1 (en) 1994-12-21 2002-09-24 Gary S. Hahn Formulations and methods for reducing skin irritation
GB2307175A (en) * 1995-11-14 1997-05-21 Steifel Lab Inc Topical composition comprising a transition metal and bicarbonate ions, particularly for the promotion of pigmentation
US6979327B2 (en) * 2000-02-25 2005-12-27 Mount Sinai School Of Medicine Treatment of vitiligo
DE10043466A1 (de) * 2000-09-04 2002-03-28 Johannes Wohlrab Manganverbindungen enthaltende Zubereitung zur topischen Applikation und deren Verwendungen
FR2814945B1 (fr) * 2000-10-09 2003-02-14 Oreal Procede de traitement de la canitie
US6630130B1 (en) 2001-07-16 2003-10-07 Pearl Grimes Sunless tanning cream
US20030224028A1 (en) * 2002-05-13 2003-12-04 Societe L'oreal S.A. Metal complexes for promoting skin desquamation and/or stimulating epidermal renewal
FR2839449B1 (fr) * 2002-05-13 2006-12-08 Oreal Utilisation d'au moins un complexe de metal comme desquamant
US20040148712A1 (en) 2002-11-29 2004-08-05 Francis Pruche Composition for coloring a keratin material, comprising at least two components, and coloring processes
JP4687436B2 (ja) * 2005-12-13 2011-05-25 ウシオ電機株式会社 エキシマ光治療器

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LU71110A1 (es) * 1974-10-15 1976-11-11
ZA786403B (en) * 1977-12-01 1979-10-31 Ici Australia Ltd Process
AU518946B2 (en) * 1979-02-23 1981-10-29 Kenneth John Hausler Trace mineral (s) cream
AU544544B2 (en) * 1980-08-20 1985-06-06 Erwin Gunther Walliczek Cuprous complex for therapeutic use
NZ198416A (en) * 1980-12-08 1984-07-31 Bio Syst Res Inc Anti-viral,anti-bacterial,and/or anti-fungal compositions containing metal oxycarboxylates
JPH0196107A (ja) * 1987-10-07 1989-04-14 Kanebo Ltd 皮膚化粧料
JPH02108612A (ja) * 1988-10-19 1990-04-20 Shizen:Kk 二価三価複合鉄塩配合化粧品
EP0424033A3 (en) * 1989-10-19 1991-07-31 Pola Chemical Industries Inc External skin preparation

Also Published As

Publication number Publication date
KR100190978B1 (ko) 1999-06-15
TW201695B (es) 1993-03-11
MY108848A (en) 1996-11-30
DE69229780D1 (de) 1999-09-16
IL101871A (en) 1997-01-10
ATE183097T1 (de) 1999-08-15
AU1785492A (en) 1992-12-30
SG45381A1 (en) 1998-01-16
IE69854B1 (en) 1996-10-02
CA2102514A1 (en) 1992-11-16
EP0584171A1 (en) 1994-03-02
IL101871A0 (en) 1992-12-30
WO1992020354A1 (en) 1992-11-26
ZA923561B (en) 1993-04-28
JPH06510275A (ja) 1994-11-17
GR3031483T3 (en) 2000-01-31
DE69229780T2 (de) 1999-12-16
NZ242748A (en) 1995-01-27
PH30792A (en) 1997-10-17
IE921559A1 (en) 1992-11-18
AU649543B2 (en) 1994-05-26
US5433942A (en) 1995-07-18
GB9110652D0 (en) 1991-07-03
EP0584171B1 (en) 1999-08-11

Similar Documents

Publication Publication Date Title
ES2137554T3 (es) 2-(2-amino-3-metoxifenil)-4-oxo-4h-(1)benzopirano para el tratamiento de desordenes proliferantes.
BR9106891A (pt) Composiçoes para o tratamento da pele
DE69532160D1 (de) Verfahren zur phototherapeutischen behandlung von proliferativen hauterkrankungen
EP0690722A4 (en) COMPOSITION AND METHOD FOR REDUCING THE TOXICITY OF BIOLOGICALLY ACTIVE FACTORS
IL101873A0 (en) Composition and method of enhancing sun tanning
PH30792A (en) Composition and method of treating depigmentation disorders.
ATE205101T1 (de) Gerät zur photodynamischen behandlung von lebewesen bzw. organen derselben
DE69826711D1 (de) Verfahren zur behandlung von pigmentierten krebszellen durch photodynamische therapie
BR9407824A (pt) Processos para tratar e para interromper e reverter alopécia androgência e para diminuir o nível de 5 &-di-hidro-testosterona no escalpo humano
KR920700634A (ko) 좌창 또는 건선 피부병을 치료하는 방법 및 여기에 사용되는 조성물
ATE258796T1 (de) Verwendung von vitamin d4-derivaten zur behandlung von hauterkrankungen
DK71387D0 (da) Terapeutisk middel til behandling af psoriasis
ES2124983T3 (es) Utilizacion de un antagonista de substancia p para el tratamiento de las manchas rojas cutaneas de origen neurogeno.
ATE311871T1 (de) Verwendung von zinksalzen der konjugierten linoleinsäuren zur behandlung von hautkrankheiten
DE69526350D1 (de) Abschuppungs-zusammensetzung
ES2068714T3 (es) Derivados de pirimidina para aumentar la actividad antitumoral.
DE59900286D1 (de) Verwendung von sphingosin-1-phosphat, sphingosin-1-phosphat-derivaten und/oder deren gemische zur behandlung von entzündlichen hautkrankheiten
AU8355598A (en) The use of 1,3,4,6-tetrahydroxy-helianthrone and its derivatives in phot odynamictherapy and certain such novel derivatives
ATE306278T1 (de) Behandlung von knochenleiden mit adrenomedullin
UA10928C2 (uk) Спосіб профілактики гіперхолестериhемії
IT1244459B (it) Composizione terapeutica per il trattamento di malattie della pelle quali vitiligine,acne,psoriasi,alopecia,ipotricosi
AU2001285419A1 (en) Methods and compositions for treating skin ulcers by topical photodynamic therapy
DE3485282D1 (de) Zusammensetzung zur behandlung von boesartigen tumoren insbesondere bei tieren.
ATE302605T1 (de) Tazaroten und uvb-phototherapie zur behandlung von psoriasis
RU96108909A (ru) Ибупрофен и флурбипрофен как противозудное средство

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 584171

Country of ref document: ES